Infectomics Screening for Novel Antiviral Drug Targets
نویسندگان
چکیده
منابع مشابه
High-throughput Screening for Novel Prostate Cancer Drug Targets
Prostate cancers form a heterogeneous group of diseases and there is a need for novel biomarkers, and for more efficient and targeted methods of treatment. In this thesis, the potential of microarray data, RNA interference (RNAi) and compound screens were utilized in order to identify novel biomarkers, drug targets and drugs for future personalized prostate cancer therapeutics. First, a bioinfo...
متن کاملHelicases as antiviral drug targets (Supplement 4)
1. We have demonstrated for the first time that the helicase of a ribonucleic acid virus, the SARS coronavirus (SARSCoV), is a valid target for drug development. 2. Using high throughput screen and chemical synthesis, several lead compounds targeting the SARS-CoV helicase have been identified. We have shown that these compounds can inhibit SARS-CoV helicase activity and viral growth in cell cul...
متن کاملMetabolic Pathways as Targets for Drug Screening
In the drug development process, candidate compounds are first screened for desirable biological properties such as effects on gene expression, signal transduction, or enzyme activity. The genetic and metabolic pathways used in the readouts are known as targets of the drug screening process. Despite advances in molecular targeting, proteomics and metabolomics, drug screening with molecular or m...
متن کاملLeishmania amastigotes as targets for drug screening
Direct drug screening against the mammalian stage of Leishmania has been hampered by cost and the time consuming effort required to accomplish it. The ability to derive transgenic Leishmania expressing reporter genes opened up new possibilities for the development of drug screening tests. Further developments to standardize and gather multiple informations could now be envisionned. We will disc...
متن کاملNovel targets for tuberculosis drug discovery.
Since the determination of the Mycobacterium tuberculosis genome sequence, various groups have used the genomic information to identify and validate targets as the basis for the development of new anti-tuberculosis agents. Validation might include many components: demonstration of the biochemical activity of the enzyme, determination of its crystal structure in complex with an inhibitor or a su...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Drug Development Research
سال: 2012
ISSN: 0272-4391
DOI: 10.1002/ddr.21027